Search

New In-vitro Model to Help Develop Drugs for Cystic Fibrosis

NEW IN-VITRO MODEL TO HELP DEVELOP DRUGS FOR CYSTIC FIBROSIS

A new laboratory model can be used to test new and existing therapeutics for cystic fibrosis, says study.

Lung function decline is delayed but not decreased in patients with cystic fibrosis and the R117H gene mutation

LUNG FUNCTION DECLINE IS DELAYED BUT NOT DECREASED IN PATIENTS WITH CYSTIC FIBROSIS AND THE R117H GENE MUTATION

Publication date: Available online 31 October 2017 Author(s): Jeffrey S. Wagener, Stefanie J. Millar, Nicole Mayer-Hamblett, Gregory...

 
 
 

LONGITUDINAL DEVELOPMENT OF INITIAL, CHRONIC AND MUCOID PSEUDOMONAS AERUGINOSA INFECTION IN YOUNG CHILDREN WITH CYSTIC FIBROSIS

Publication date: Available online 28 October 2017 Author(s): S.L. Heltshe, U. Khan, V. Beckett, A. Baines, J. Emerson, D.B. Sanders,...

What Should Gene Therapy Cost?

WHAT SHOULD GENE THERAPY COST?

By the time that the FDA's advisory committee gave a near-instantaneous and unanimous thumbs-up for gene therapy to treat a form of...

 
 
 
Gene editing technology can now fix cystic fibrosis

GENE EDITING TECHNOLOGY CAN NOW FIX CYSTIC FIBROSIS

Scientists at MIT and Harvard have discovered a way to use CRISPR technology to cure cystic fibrosis. With this new gene editor, they...

MECHANISMS OF HUMORAL IMMUNE RESPONSE AGAINST PSEUDOMONAS AERUGINOSA BIOFILM INFECTION IN CYSTIC FIBROSIS

Publication date: Available online 21 October 2017 Author(s): Renan Marrichi Mauch, Peter Østrup Jensen, Claus Moser, Carlos Emilio...

 
 
 

GLUCOSE TRAJECTORIES IN CYSTIC FIBROSIS AND THEIR ASSOCIATION WITH PULMONARY FUNCTION

Publication date: Available online 14 October 2017 Author(s): Quitterie Reynaud, Muriel Rabilloud, Sylvain Roche, Stéphanie Poupon-Bourdy,...

PROTECTION OF TUBULAR EPITHELIAL CELLS DURING RENAL INJURY VIA POST-TRANSCRIPTIONAL CONTROL OF BMP7

Abstract Severe injury of renal tubular epithelial cells may cause acute renal failure, the progression of which results in renal fibrosis,...

 
 
 
Discovery Research in the Spotlight

DISCOVERY RESEARCH IN THE SPOTLIGHT

Medical science can seem to zig and zag from one study to the next. But there's a method to that madness. It's called the scientific...

I Finally Found the 1 Acne Spot Treatment That Works on My Problematic Skin

I FINALLY FOUND THE 1 ACNE SPOT TREATMENT THAT WORKS ON MY PROBLEMATIC SKIN

I've suffered from hormonal cystic acne since I hit puberty, and those huge, painful, and embarrassing blemishes have never stopped...

 
 
 

16S RRNA GENE SEQUENCING REVEALS SITE-SPECIFIC SIGNATURES OF THE UPPER AND LOWER AIRWAYS OF CYSTIC FIBROSIS PATIENTS

Publication date: Available online 18 August 2017 Author(s): Sarah K. Lucas, Robert Yang, Jordan M. Dunitz, Holly C. Boyer, Ryan C....

CONATUS PHARMA ANNOUNCES COMPLETION OF ENROLLMENT IN ENCORE-NF PHASE IIB CLINICAL TRIAL OF EMRICASAN IN PATIENTS WITH NASH FIBROSIS

Life Sciences Jobs ...

 
 
 
What Is Cystic Acne, and How Should You Treat It?

WHAT IS CYSTIC ACNE, AND HOW SHOULD YOU TREAT IT?

Acne is a pain. Not only can it be very damaging when it comes to self-confidence, but some spots can also be incredibly painful and...

 
 
 
 
 
 

COMMENT ON DATA SPARSITY - DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF SYSTEMIC ALKYL QUINOLONES FOR P. AERUGINOSA IN CYSTIC FIBROSIS: A LONGITUDINAL STUDY

Publication date: Available online 24 July 2017 Author(s): Erfan Ayubi, Jamal Hallajzadeh, Saeid Safiri

INCREASED PREVALENCE OF COLONIC ADENOMAS IN PATIENTS WITH CYSTIC FIBROSIS

Publication date: Available online 23 July 2017 Author(s): Mehdi Hegagi, Shawn D. Aaron, Paul James, Rakesh Goel, Avijit Chatterjee Background...

 
 
 
Bicarbonate in cystic fibrosis

BICARBONATE IN CYSTIC FIBROSIS

Publication date: Available online 18 July 2017 Author(s): Karl Kunzelmann, Rainer Schreiber, Hans Beat Hadorn Background Cystic fibrosis...

Vertex Touts Positive Triple-Drug Data For Cystic Fibrosis Patients

VERTEX TOUTS POSITIVE TRIPLE-DRUG DATA FOR CYSTIC FIBROSIS PATIENTS

Vertex Pharmaceuticals continued its march away from being the biggest loser in the hepatitis C wars and toward increasing dominance...